Trial Profile
A 6-Month, Randomized, Open-Label, Active-Comparator Controlled, Parallel-Group Study With a 6-Month Extension to Evaluate the Safety and Efficacy of Alendronate Sodium 70 mg/Vitamin D3 5600 I.U. Combination Tablets Versus Calcitriol in the Treatment of Osteoporosis in Postmenopausal Women in China
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 05 May 2022
Price :
$35
*
At a glance
- Drugs Alendronic acid/colecalciferol (Primary) ; Calcitriol
- Indications Postmenopausal osteoporosis
- Focus Therapeutic Use
- Sponsors Organon
- 05 Oct 2013 Results presented at the 35th Annual Meeting of the American Society for Bone and Mineral Research.
- 05 Oct 2013 Primary endpoint 'Lumbar-spine-bone-mineral-density' has been met.
- 01 Jan 2013 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.